Immunotherapy‑based combinations versus standard first‑line and hypothyroidism risk

• G. Roviello ^[1] ; D. Villari ^[1] ; R. Roud ^[2]
  1. [1] University of Florence

     University of Florence

     Firenze, Italia

     
  2. [2] Department of Cell Systems and Anatomy, University of Texas Health San Antonio, San Antonio, TX, USA
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 22, Nº. 9, 2020, págs. 1664-1665
• Idioma: inglés
• Texto completo no disponible (Saber más ...)